Masimo Corporation (MASI) Shares Bought by Vanguard Group Inc.
Vanguard Group Inc. lifted its stake in shares of Masimo Corporation (NASDAQ:MASI) by 6.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,935,693 shares of the medical equipment provider’s stock after purchasing an additional 318,060 shares during the period. Vanguard Group Inc. owned 9.50% of Masimo Corporation worth $450,036,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Prudential Financial Inc. increased its stake in shares of Masimo Corporation by 14.4% during the 2nd quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock worth $50,442,000 after purchasing an additional 69,810 shares during the last quarter. American Century Companies Inc. grew its stake in Masimo Corporation by 98.0% in the 2nd quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock valued at $19,100,000 after buying an additional 103,656 shares in the last quarter. D L Carlson Investment Group Inc. grew its stake in Masimo Corporation by 32.4% in the 2nd quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock valued at $4,216,000 after buying an additional 11,315 shares in the last quarter. Robeco Institutional Asset Management B.V. grew its stake in Masimo Corporation by 27.1% in the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after buying an additional 233,412 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Masimo Corporation by 11.2% in the 1st quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock valued at $42,466,000 after buying an additional 45,833 shares in the last quarter. Institutional investors own 83.21% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.watchlistnews.com/masimo-corporation-masi-shares-bought-by-vanguard-group-inc/1609682.html.
Masimo Corporation (NASDAQ MASI) opened at 86.60 on Thursday. The firm has a 50-day moving average of $85.32 and a 200 day moving average of $90.25. Masimo Corporation has a one year low of $53.78 and a one year high of $104.71. The company has a market capitalization of $4.50 billion, a P/E ratio of 14.19 and a beta of 0.82.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. The firm had revenue of $192.90 million during the quarter, compared to analysts’ expectations of $189.03 million. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The company’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.57 earnings per share. On average, equities analysts forecast that Masimo Corporation will post $2.80 EPS for the current fiscal year.
A number of research analysts recently weighed in on the stock. Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. BidaskClub lowered shares of Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research upgraded shares of Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. Stifel Nicolaus assumed coverage on shares of Masimo Corporation in a research note on Monday, July 10th. They issued a “buy” rating and a $105.00 price objective for the company. Finally, BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research note on Monday, August 14th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the company. Masimo Corporation has a consensus rating of “Hold” and an average price target of $97.00.
In other news, Director Sanford Fitch sold 6,000 shares of the stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $91.89, for a total value of $551,340.00. Following the completion of the sale, the director now directly owns 89,249 shares of the company’s stock, valued at $8,201,090.61. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Rick Fishel sold 15,000 shares of the firm’s stock in a transaction on Tuesday, July 11th. The shares were sold at an average price of $92.85, for a total transaction of $1,392,750.00. Following the transaction, the insider now directly owns 35,022 shares of the company’s stock, valued at $3,251,792.70. The disclosure for this sale can be found here. Over the last three months, insiders sold 112,000 shares of company stock valued at $10,444,090. Corporate insiders own 16.60% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.